Healthcare Economics

Pharmaceuticals Healthcare Policy Healthcare Policy Health Policy Drug Pricing Drug Manufacturers Prescription Drugs Drug Pricing Economics Policy Pharmaceutical Industry

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact

The executive order aims to reduce domestic drug costs but raises fears of higher prices abroad and threats to pharmaceutical innovation.

Trump's Executive Order Enacts Global Benchmark for U.S. Drug Prices

Trump Expands Drug Pricing Model to Medicare and Medicaid, Targets Global Parity

Rep. Ro Khanna Files Legislation to Codify Trump’s Drug Pricing Executive Order

Japan Moves to Make Standard Childbirth Free Under Public Insurance by 2026

Trump’s Executive Order Targets Prescription Drug Prices and PBMs

Newsom Pushes State Regulation of PBMs and CalRx Expansion in 2025 Budget Plan

Trump Signs Sweeping Order to Cap U.S. Drug Prices at Global Lows

WHO Report Highlights Uneven Progress in Global Nursing Workforce

New Survey Reveals U.S. Illicit Opioid Use Far Higher Than Federal Estimates

Trump to Revive Medicare Drug Pricing Plan via Executive Order

Wall Street Journal Denounces Trump's Medicaid Drug Pricing Plan

Dr. Oz Proposes Medicaid Expansion Cuts, Citing Cost Inefficiencies

Supreme Court Limits Medicare Payments to Hospitals in Key Ruling

Texas Reports $121.8M in November Hospital Costs for Undocumented Patients

Pharma CEOs Urge EU to Reform Pricing Policies as U.S. Investments Surge

Trump Administration Weighs Pilot to Tie U.S. Drug Prices to Global Benchmarks

Trump Signs Executive Order Targeting Lower Drug Prices and Medicare Reforms

U.S. Abortion Numbers Show Slight Increase as Telehealth Gains Traction

CMS Rejects Medicare and Medicaid Coverage for Anti-Obesity Drugs